Multi-modal data integration reveals functionally credible predictive…
Researchers can now reliably distinguish true cancer drivers from false alarms using patient tumors, helping oncologists select treatments that actually work for individual ovarian cancer patients.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Personalized neoantigen-pulsed autologous dendritic cells in…
A personalized vaccine approach shows early promise in glioblastoma, a brain cancer with no cure, opening new possibilities for training the immune system to fight this aggressive disease.
Early cancer detection or preventionIntegrated multiclass driver ctDNA profiling enables MPNST detection…
A blood test can detect nerve sheath cancer recurrence months before symptoms appear, potentially allowing earlier intervention in this rare but lethal tumor.
Novel or significantly improved treatmentEfficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory…
CAR T-cell therapy produces strong responses in hard-to-treat lymphoma patients, though manageable side effects require careful medical oversight during treatment.
Near-term implementable findingTime to benefit of incretin-based therapies in adiposity-related…
Patients know how quickly to expect improvement from newer diabetes drugs used for heart failure, helping them make informed decisions about starting treatment.